CompletedPhase 3NCT00052299
Chemotherapy With or Without Gemtuzumab Ozogamicin in Treating Older Patients With Acute Myeloid Leukemia
Studying Acute erythroid leukemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- European Organisation for Research and Treatment of Cancer - EORTC
- Principal Investigator
- Sergio Amadori, MDAzienda Ospedallera Universitaria - Policlinico Tor Vergata, Roma
- Intervention
- cytarabine(drug)
- Enrollment
- 472 enrolled
- Eligibility
- 61-75 years · All sexes
- Timeline
- 2002 – 2012
Study locations (30)
- A. oe. Krankenhaus der Barmherzigen Schwestern Kinderabteilung, Linz, Austria
- Allgemeines Krankenhaus - Universitatskliniken, Vienna, Austria
- AZ Sint-Jan, Bruges, Belgium
- Institut Jules Bordet, Brussels, Belgium
- Hopital Universitaire Erasme, Brussels, Belgium
- Centre Hospitalier Universitaire Brugmann, Brussels, Belgium
- Universitair Ziekenhuis Antwerpen, Edegem, Belgium
- Hopital de Jolimont, Haine-Saint-Paul, Belgium
- CHU Liege - Domaine Universitaire du Sart Tilman, Liège, Belgium
- Centre Hospitalier Peltzer-La Tourelle, Verviers, Belgium
- Hopital Edouard Herriot, Lyon, France
- Centre Antoine Lacassagne, Nice, France
- Hotel Dieu de Paris, Paris, France
- Klinikum der Albert - Ludwigs - Universitaet Freiburg, Freiburg im Breisgau, Germany
- Ruprecht - Karls - Universitaet Heidelberg, Heidelberg, Germany
- +15 more locations on ClinicalTrials.gov
Collaborators
Gruppo Italiano Malattie EMatologiche dell'Adulto
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00052299 on ClinicalTrials.govOther trials for Acute erythroid leukemia
Additional recruiting or active studies for the same condition.